These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23060581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Associations of pretreatment serum total testosterone measurements with pathology-detected Gleason score cancer.
    Porcaro AB, Petrozziello A, Ghimenton C, Migliorini F, Sava T, Caruso B, Romano M, Cavalleri S, Artibani W.
    Urol Int; 2014; 93(3):269-78. PubMed ID: 24334919
    [Abstract] [Full Text] [Related]

  • 8. Serum total testosterone is a significant preoperative variable independently contributing to separating the prostate cancer population into prostatectomy Gleason score groups.
    Porcaro AB, Petrozziello A, Ghimenton C, Migliorini F, Sava T, Caruso B, Cocco C, Romano M, Cavalleri S, Artibani W.
    Urol Int; 2013; 91(1):55-61. PubMed ID: 23751412
    [Abstract] [Full Text] [Related]

  • 9. The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy.
    Porcaro AB, Caruso B, Terrin A, De Luyk N, Cacciamani G, Corsi P, Inverardi D, De Marchi D, Baldassarre R, Cerruto M, Ghimenton C, Brunelli M, Zecchini Antoniolli S, Petrozziello A, Artibani W.
    Arch Ital Urol Androl; 2016 Mar 31; 88(1):17-22. PubMed ID: 27072171
    [Abstract] [Full Text] [Related]

  • 10. Investigative clinical study on prostate cancer part IV: exploring functional relationships of total testosterone predicting free testosterone and total prostate-specific antigen in operated prostate cancer patients.
    Porcaro AB, Petrozziello A, Migliorini F, Lacola V, Romano M, Sava T, Ghimenton C, Caruso B, Zecchini Antoniolli S, Rubilotta E, Monaco C, Comunale L.
    Urol Int; 2011 Mar 31; 86(4):399-406. PubMed ID: 21508618
    [Abstract] [Full Text] [Related]

  • 11. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug 31; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM, Casey RG, Hong MK, Pedersen J, Connolly S, Peters J, Harewood L, Gleave ME, Costello AJ, Hovens CM, Goldenberg SL.
    BJU Int; 2012 Jul 31; 110(1):36-42. PubMed ID: 22085203
    [Abstract] [Full Text] [Related]

  • 14. High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy.
    Porcaro AB, Petroziello A, Brunelli M, De Luyk N, Cacciamani G, Corsi P, Sebben M, Tafuri A, Tamanini I, Caruso B, Ghimenton C, Monaco C, Artibani W.
    Urol Int; 2016 Jul 31; 96(4):470-8. PubMed ID: 26845458
    [Abstract] [Full Text] [Related]

  • 15. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
    Bantis A, Zissimopoulos A, Athanasiadou P, Gonidi M, Agelonidou E, Strataki A, Matthaios D, Tsartsarakis A.
    Hell J Nucl Med; 2007 Jul 31; 10(1):56-61. PubMed ID: 17450256
    [Abstract] [Full Text] [Related]

  • 16. Investigative clinical study on prostate cancer Part V: Luteinizing hormone and the pituitary-testicular-prostate axis at the time of initial diagnosis and subsequent cluster selection of the patient population.
    Porcaro AB, Petrozziello A, Migliorini F, Caruso B, Cocco C, Sava T, Ghimenton C, Romano M, Monaco C, Comunale L.
    Anticancer Res; 2011 Mar 31; 31(3):1071-8. PubMed ID: 21498741
    [Abstract] [Full Text] [Related]

  • 17. Hormonal predictors of prostate cancer.
    Sofikerim M, Eskicorapci S, Oruç O, Ozen H.
    Urol Int; 2007 Mar 31; 79(1):13-8. PubMed ID: 17627161
    [Abstract] [Full Text] [Related]

  • 18. Investigative clinical study on prostate cancer part III: exploring total PSA and free testosterone distributions and linear correlations in groups and subgroups of operated prostate cancer patients according to the total PSA/FT ratio.
    Porcaro AB, Petrozziello A, Romano M, Sava T, Ghimenton C, Caruso B, Migliorini F, Zecchini Antoniolli S, Rubilotta E, Lacola V, Monaco C, Comunale L.
    Urol Int; 2010 Mar 31; 85(4):406-9. PubMed ID: 20948186
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.